Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Asset Writedowns and Impairment of $78000.0 for Q3 2025, down 74.59% year-over-year from $307000.0 in Q3 2024, and up 252.94% quarter-over-quarter from -$51000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Asset Writedowns and Impairment for 9 consecutive years, with $78000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Asset Writedowns and Impairment fell 74.59% year-over-year to $78000.0; the TTM figure through Sep 2025 stood at $358000.0 (down 45.26% YoY), while the FY2024 annual figure was $485000.0, up 35.85% from the prior year.
- Asset Writedowns and Impairment climbed to $78000.0 in Q3 2025 per XTNT's latest filing, from -$51000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $864000.0 in Q4 2021 and bottomed at -$210000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $204736.8 across 5 years, with a median of $129000.0 in 2024.
- Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment jumped 7754.55% — and 2024, when it tumbled 412.2%.
- Xtant Medical Holdings' Asset Writedowns and Impairment stood at $864000.0 in 2021, then tumbled by 71.76% to $244000.0 in 2022, then sank by 116.8% to -$41000.0 in 2023, then sank by 412.2% to -$210000.0 in 2024, then soared by 137.14% to $78000.0 in 2025.
- Business Quant data shows XTNT's Asset Writedowns and Impairment at $78000.0 in Q3 2025, -$51000.0 in Q2 2025, and $541000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 46.53 Mn | 28.93 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Sep 30, 2024 | 307,000.00 |
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |